Leng Shusheng, Xie Fei, Liu Junyi, Shen Junyi, Quan Guangqian, Wen Tianfu
Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China.
General Surgery Department, Affiliated Hospital/Clinical Medical College of Chengdu University, Chengdu, China.
Front Oncol. 2021 Jun 10;11:683629. doi: 10.3389/fonc.2021.683629. eCollection 2021.
Lethal giant larvae (Lgl), scaffolding proteins, regulate the epithelial cell apicobasal polarity in Drosophila. They play important roles in asymmetric cell division, cell migration, and progenitor cells self-renewal as tumor suppressors. One of Lgl mammalian homologues proteins, LLGL2 overexpression has been reported in ER+ breast cancer and promotes tumor proliferation through regulating leucine uptake. Nonetheless, the role of LLGL2 in hepatocellular carcinoma (HCC) is still unknown.
TCGA dataset mining, qRT-PCR, Western blot along with immunohistochemistry assays were employed to explore LLGL2 expression in human HCC samples and cell lines. Moreover, the clinical value of LLGL2 was investigated in 156 HCC patients. Furthermore, the role as well as the molecular mechanism of LLGL2 in the progression of HCC was explored through a series of and experiments.
LLGL2 was up-regulated in HCC tissues, which was related with certain clinicopathological features including tumor number, vascular invasion as well as advanced stage. High expression of LLGL2 predicted poor prognosis after hepatectomy. LLGL2 promoted HCC cells proliferation, migration and invasion through PI3K/ATK signaling by promoting calcium ion influx.
Our study identified that LLGL2 is a tumor promoter in HCC for the first time, which could potentially be utilized as a new biomarker and a therapeutic target for HCC.
致死性巨幼虫(Lgl)作为一种支架蛋白,可调节果蝇上皮细胞的顶-基极性。它们作为肿瘤抑制因子,在不对称细胞分裂、细胞迁移和祖细胞自我更新中发挥重要作用。据报道,Lgl的哺乳动物同源蛋白之一LLGL2在雌激素受体阳性(ER+)乳腺癌中过表达,并通过调节亮氨酸摄取促进肿瘤增殖。然而,LLGL2在肝细胞癌(HCC)中的作用仍不清楚。
采用TCGA数据集挖掘、qRT-PCR、蛋白质免疫印迹以及免疫组化分析,以探究LLGL2在人肝癌样本和细胞系中的表达。此外,还对156例肝癌患者的LLGL2临床价值进行了研究。此外,通过一系列实验探究了LLGL2在肝癌进展中的作用及其分子机制。
LLGL2在肝癌组织中上调,这与包括肿瘤数量、血管侵犯以及晚期等某些临床病理特征相关。LLGL2高表达预示肝切除术后预后不良。LLGL2通过促进钙离子内流,经PI3K/ATK信号通路促进肝癌细胞增殖、迁移和侵袭。
我们的研究首次确定LLGL2是肝癌中的肿瘤促进因子,其有可能被用作肝癌的新型生物标志物和治疗靶点。